Milatuzumab (Anti-CD74)
Milatuzumab (Anti-CD74) is a humanized monoclonal antibody targeting CD74, a integral membrane protein. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death. MW:145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2551 |
Sku # | A2551-1mg |
Pricing | 1mg, $370.00 |